Evaluation of patients with hepatocellular carcinomas using [11C]acetate and [18F]FDG PET/CT: A preliminary study

Applied Radiation and Isotopes

Volumn 67, Issue 7-8, 2009, Pages 1195-1198

  Hwang, Kyung Hoon ^a   Choi, Duck Joo ^a   Lee, Sang Yoon ^a   Lee, Min Kyung ^a   Choe, Wonsick ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

11C acetate; F 18 fluorodeoxyglucose ( 18F FDG); Hepatocellular carcinoma (HCC); Integrated positron emission tomography and computed tomography (PET CT)

Indexed keywords

[11C]ACETATE; F-18 FLUORODEOXYGLUCOSE ([18F]FDG); FDG PET; HEPATOCELLULAR; HEPATOCELLULAR CARCINOMA; HEPATOCELLULAR CARCINOMA (HCC); HIGH SENSITIVITY; INTEGRATED POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET/CT); LOW SENSITIVITY; MEAN AGES; METASTATIC LESIONS; STANDARDIZED UPTAKE VALUES;

COMPUTERIZED TOMOGRAPHY; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS;

POSITRON EMISSION TOMOGRAPHY;

CARBON 11; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER DISEASE; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ACETATES; ADULT; CARBON RADIOISOTOPES; CARCINOMA, HEPATOCELLULAR; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 67349183386     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.02.011     Document Type: Article

References (13)

1. Antoch G., Stattaus J., Nemat A.T., Marnitz S., Beyer T., Kuehl H., Bockisch A., Debatin J.F., and Freudenberg L.S. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229 (2003) 526-533
2. Böhm B., Voth M., Geoghegan J., Hellfritzsch H., Petrovich A., Scheele J., and Gottschild D. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J. Cancer Res. Clin. Oncol. 130 (2004) 266-272
3. Goerres G.W., von Schulthess G.K., and Steinert H.C. Why most PET of lung and head and neck cancer will be PET/CT. J. Nucl. Med. 45 (2004) 66S-71S
4. 11C]acetate PET imaging in hepatocellular carcinoma and other liver masses. J. Nucl. Med. 44 (2003) 213-221
5. Ho C.-L., Yeung D.W.C., and Cheng T.K.C. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J. Nucl. Med. 48 (2007) 902-909
6. Iwata Y., Shiomi S., Sadaki N., Jomura H., Nishiguchi S., Seki S., et al. Clinical usefulness of positron emission tomography scanning with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann. Nucl. Med. 14 (2000) 121-126
7. Khan M.A., Combs C.S., Brunt E.M., Lowe V.J., Wolverson M.K., Solomon H., Collins B.T., and Di Bisceglie A.M. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J. Hepatol. 32 (2000) 792-797
8. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., von Schulthess G.K., and Steinert H.C. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N. Engl. J. Med. 348 (2003) 2500-2507
9. Lee J.D., Yun M., Lee J.M., Choi Y., Choi Y.H., Kim J.S., Kim S.J., Kim K.S., Yang W.I., Park Y.N., Han K.H., Lee W.J., Yoo N., Lim S.M., and Park J.H. Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging 31 (2004) 1621-1630
10. 18F]FDG uptake. J. Nucl. Med. 46 (2005) 1753-1759
11. Okazumi S., Isono K., Enomoto K., Kikuchi T., Ozaki M., Yamamoto H., et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J. Nucl. Med. 33 (1992) 333-339
12. 18F]FDG-PET. J. Nucl. Med. 36 (1995) 1811-1817
13. 18F]FDG positron emission tomography for imaging of hepatocellular carcinoma. Am. J. Gastroenterol. 94 (1999) 3314-3319